Alzheimer’s Drug Debuts to Controversy
For the first time in 18 years, U.S. health regulators approved a new drug in June to treat Alzheimer’s — in spite of concerns over whether or not the therapy is effective.
For the first time in 18 years, U.S. health regulators approved a new drug in June to treat Alzheimer’s — in spite of concerns over whether or not the therapy is effective.